Skip to main content
. 2022 Feb 24;15(3):283. doi: 10.3390/ph15030283

Figure 2.

Figure 2

Previously reported indirect and direct FOXM1 inhibitors. Indirect FOXM1 inhibitors: (a) oxalilplatin and (b) daunorubicin. Direct FOXM1 inhibitors: (c) thiostrepton and (d) troglitazone.